Imane Kerif Navigates Controversial Career in Boxing
In a recent interview with the French sports publication L’Equipe, boxer Imane Kerif revealed that she has the SRY gene, which is typically found on the Y chromosome in biological males. She’s currently undergoing hormone treatment aimed at reducing her testosterone levels as she prepares for the 2024 Olympics.
Despite this, Kerif insists that she does not identify as transgender. “Everyone has different genetics, different hormone levels. I’m not transgender. My differences are natural. This is who I am,” she stated. She expressed a strong sense of acceptance about her identity and her natural differences, indicating that she is not altering her biology against nature.
Looking ahead, Kerif mentioned her willingness to take a genetic gender test to compete at the 2028 Olympics in Los Angeles, acknowledging that such a requirement is likely. “I will take it if needed. I have no problem with that,” she said confidently.
However, the situation has drawn scrutiny. The Independent Council for Women’s Sport (ICONS) recently made a statement regarding her hospitalization and noted that Kerif had confirmed a male identity, which raises questions about eligibility under current World Boxing Rules. These rules specify that men cannot compete in women’s Olympic boxing. Following this revelation, she has reportedly planned to pursue professional boxing in Europe, even while expressing intent to clear herself through a gender test for future competitions.
Kerif has previously faced challenges, having been disqualified from the IBA for not meeting gender eligibility criteria. The IBA president stated at the time that she had XY chromosomes based on unpublished DNA test results. The International Olympic Committee (IOC) later defended Kerif, suggesting that decisions made by the IBA were abrupt and lacked fairness.
In response to ongoing debates about gender testing in sports, the international governing body, World Boxing, implemented a new policy mandating such tests to ensure that only women compete in female categories. Kerif has called for regulations that might prevent participation in competitions until test results are finalized.
Interestingly, Kerif missed an international boxing tournament in the Netherlands last summer, claiming she failed to register before the deadline. Meanwhile, the discourse around genetic testing has also reached political circles; former President Donald Trump commented on the need for robust testing protocols for the upcoming 2028 Olympics.
